About Asarina Pharma
Asarina Pharma is a company based in Umea (Sweden) founded in 2006. It operates as a HealthTech. Asarina Pharma has raised $28.01 million across 4 funding rounds from investors including Handelsbanken, Idinvest Partners and Ergomed. The company has 1 employees as of August 31, 2024. Asarina Pharma offers products and services including Sepranolone. Asarina Pharma operates in a competitive market with competitors including Agile Therapeutics, Auxilium Pharmaceuticals, Xanodyne Pharmaceuticals, Microchips Biotech and Marius Pharmaceuticals, among others.
- Headquarter Umea, Sweden
- Employees 1 as on 31 Aug, 2024
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Asarina Pharma Ab
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$28.01 M (USD)
in 4 rounds
-
Latest Funding Round
-
Investors
Handelsbanken
& 7 more
-
Employee Count
1
as on Aug 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Asarina Pharma
Asarina Pharma offers a comprehensive portfolio of products and services, including Sepranolone. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Sepranolone is developed for neuroendocrinological disorder treatment.
Funding Insights of Asarina Pharma
Asarina Pharma has successfully raised a total of $28.01M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Last Round
-
First Round
First Round
(08 Mar 2013)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2019 | Amount | Series A - Asarina Pharma | Valuation |
investors |
|
| Nov, 2016 | Amount | Series A - Asarina Pharma | Valuation | Idinvest Partners , Ergomed |
|
| Jun, 2015 | Amount | Series A - Asarina Pharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Asarina Pharma
Asarina Pharma has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Handelsbanken, Idinvest Partners and Ergomed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Research funding is provided for Baltic and Eastern European studies.
|
Founded Year | Domain | Location | |
|
Equity investments are provided to low and middle market companies.
|
Founded Year | Domain | Location | |
|
Early-stage life science investments in Sweden are targeted.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Asarina Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Asarina Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Asarina Pharma Comparisons
Competitors of Asarina Pharma
Asarina Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Agile Therapeutics, Auxilium Pharmaceuticals, Xanodyne Pharmaceuticals, Microchips Biotech and Marius Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for women's healthcare are developed and offered.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics and drug-device combinations for urology and sexual health
|
|
| domain | founded_year | HQ Location |
Developer of drugs for women's health and pain management
|
|
| domain | founded_year | HQ Location |
Microchip implants for wireless drug delivery are developed.
|
|
| domain | founded_year | HQ Location |
A proprietary oral testosterone replacement therapy platform is developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Asarina Pharma
Frequently Asked Questions about Asarina Pharma
When was Asarina Pharma founded?
Asarina Pharma was founded in 2006 and raised its 1st funding round 7 years after it was founded.
Where is Asarina Pharma located?
Asarina Pharma is headquartered in Umea, Sweden.
Who is the current CEO of Asarina Pharma?
Peter Nordkild is the current CEO of Asarina Pharma.
Is Asarina Pharma a funded company?
Asarina Pharma is a funded company, having raised a total of $28.01M across 4 funding rounds to date. The company's 1st funding round was a Series A of $7.02M, raised on Mar 08, 2013.
How many employees does Asarina Pharma have?
As of Aug 31, 2024, the latest employee count at Asarina Pharma is 1.
What does Asarina Pharma do?
Asarina Pharma, a Swedish biotech company, is engaged in the development of Sepranolone for treating Allopregnanolone-related stress, compulsion, menstrual, and neurological disorders. The company operates in the healthcare sector, specifically biotechnology, targeting neuroendocrinological conditions. Its solutions are built on over 40 years of research into Allopregnanolone-related disorders, with a new family of GAMSA compounds (GABA-A Modulating Steroid Antagonists) aimed at delivering efficacious and safe drugs for widely untreated conditions such as Tourette Syndrome, OCD, and PMDD. Research and clinical trials, including Phase IIa studies, are conducted to validate the safety and efficacy of its pharmaceutical offerings.
Who are the top competitors of Asarina Pharma?
Asarina Pharma's top competitors include Agile Therapeutics, Auxilium Pharmaceuticals and Marius Pharmaceuticals.
What products or services does Asarina Pharma offer?
Asarina Pharma offers Sepranolone.
Who are Asarina Pharma's investors?
Asarina Pharma has 8 investors. Key investors include Handelsbanken, Idinvest Partners, Ergomed, Karolinska Development, and Fjarde AP-fonden.